SeLux Diagnostics

company

About

SeLux Diagnostics is a developer of the next-generation phenotyping platform that enables personalized antibiotic therapies for patients.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.80M
Industries
Biotechnology,Health Care,Health Diagnostics,Therapeutics
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

SeLux Diagnostics is a developer of the Next-Generation Phenotyping (NGP) platform that enables personalized antibiotic therapies for patients.

The company was founded in 2014 and is based in Charlestown, MA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.80M
SeLux Diagnostics has raised a total of $2.80M in funding over 2 rounds. Their latest funding was raised on Oct 19, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 19, 2021 Grant $2.80M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
SeLux Diagnostics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant